J. Larry Jameson | |
|---|---|
![]() Jameson in 2024 | |
| 10thPresident of the University of Pennsylvania | |
Incumbent | |
| Assumed office March 13, 2025 | |
| Interim President of the University of Pennsylvania | |
| In office December 12, 2023 – March 13, 2025 | |
| Preceded by | Liz Magill |
| Personal details | |
| Born | James Larry Jameson III Fort Benning,Georgia, U.S. |
| Education | University of North Carolina at Chapel Hill (BS,MD,PhD) |
| Scientific career | |
| Fields | Biochemistry Endocrinology |
| Institutions | |
| Thesis | Regulation of Microtubule Assembly and Steady-State Dynamics (1981) |
James Larry Jameson III is the 10th president of theUniversity of Pennsylvania, appointed in March 13, 2025, with a term extending through June 2027. He initially assumed the role of Interim President in December 2023. Prior to his presidency, from 2011 to 2023, Jameson served as Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Perelman School of Medicine, where he led significant advancements in medical education, research, and patient care.[1]
Jameson was born onFort Benning inColumbus, Georgia, and raised inAsheville, North Carolina.[2][3]
From theUniversity of North Carolina at Chapel Hill, Jameson received aBachelor of Science with a major in chemistry with honors in 1976, aDoctor of Medicine in 1981, and aPh.D. in biochemistry in 1981.[4]
Jameson's doctoral dissertation was titled,Regulation of microtubule assembly and steady-state dynamics.[5] During his doctoral studies at UNC, he received the Merck Book Award in 1978, theAlpha Omega Alpha membership in 1980, and the Lange Book Award in 1980. In 1981, he received the Isaac Hall Manning Award and a Merit Award from theUNC School of Medicine.[6]
In 1981, Jameson started as an intern and resident atMassachusetts General Hospital inBoston. In 1983, he became a research fellow at theHoward Hughes Medical Institute's Laboratory of Molecular Endocrinology, studyingtranscriptional regulation in endocrine genes with a focus on nuclear hormone receptors.[7][6]
In 1985, Jameson joinedHarvard Medical School as an instructor in medicine, advancing to assistant professor in 1987 and associate professor by 1992.[6] During this period, he served as chief of the Thyroid Unit at Massachusetts General Hospital from 1987 to 1993, where he co-directed training programs in endocrinology, diabetes, andreproductive biology. His research included projects ongene expression regulation andhormone receptor interactions with pituitary genes, supported by grants from theNational Institute of Diabetes and Digestive and Kidney Diseases.[6] In 1990, his contributions were recognized with election to theAmerican Society for Clinical Investigation.[7][6]
In 1993, Jameson transitioned toNorthwestern University'sFeinberg School of Medicine as the Charles F. Kettering Professor of Medicine and chief of the Division of Endocrinology, Metabolism, and Molecular Medicine. He directed Northwestern’s Training Program in Endocrinology and Metabolism, focusing on endocrine gene transcription,thyroid disease, andpituitary tumor pathogenesis. He was elected a member of theAssociation of American Physicians in 1995. That same year, he began contributing as co-editor-in-chief of the textbook,Endocrinology, a reference work on clinical and molecular endocrinology.[7][6]
In 2000, Jameson became chairman of the Department of Medicine at Northwestern University, overseeing a broad range of research initiatives and patient care services across multiple specialties. He directed the Hormone Action and Cancer Group at theRobert H. Lurie Comprehensive Cancer Center, continuing his research into hormone receptor action and cancer biology. In 2004, Jameson was elected as a fellow of theAmerican Academy of Arts and Sciences and became afellow of the American Association for the Advancement of Science in 2005. The following year, he was inducted into theNational Academy of Medicine.[7][6]
In 2007, Jameson was appointed dean of the Feinberg School of Medicine and vice president for medical affairs at Northwestern University. In these roles, he expanded research initiatives and emphasized molecular medicine in education. That same year, he also joinedHarrison’s Principles of Internal Medicine as an editor, contributing to its 15th through 21st editions and authoring sections on endocrinology, genetics, andsex development.[6]
In 2011, Jameson joined theUniversity of Pennsylvania, serving as the executive vice president for theUniversity of Pennsylvania Health System and Dean of thePerelman School of Medicine at the University of Pennsylvania. His responsibilities included expanding research and clinical infrastructure and directing strategic growth in medical education. His editorial roles further expanded as he became editor-in-chief ofThe Journal of Clinical Endocrinology and Metabolism from 2016 to 2021, and editor-in-chief ofJournal of the Endocrine Society from 2016 to 2019.
In December 2023, Jameson was appointed interim president of the University of Pennsylvania, following the resignation ofLiz Magill amid hercongressional hearing controversies.[8] In March 2025, he was elevated to President to serve until 2027.[9][10][11]
Jameson's paternal lineage traces back to his great-great-great grandfather, William Jameson Sr., who emigrated from Ireland tocolonial America in 1750.[2] William Jameson settled inEasley, South Carolina, and served in theAmerican Revolutionary War.[2] For four subsequent generations, the family remained inSouth Carolina until Jameson's father relocated to Asheville, North Carolina, where Jameson was raised.[2]
{{cite web}}: CS1 maint: multiple names: authors list (link){{cite web}}: CS1 maint: multiple names: authors list (link)